scispace - formally typeset
M

Maria J G T Vehreschild

Researcher at Goethe University Frankfurt

Publications -  224
Citations -  9720

Maria J G T Vehreschild is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 36, co-authored 174 publications receiving 5839 citations. Previous affiliations of Maria J G T Vehreschild include University of Bonn & University of Cologne.

Papers
More filters
Journal ArticleDOI

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).

TL;DR: Cardiac magnetic resonance imaging revealed cardiac involvement and ongoing myocardial inflammation in patients with recent coronavirus disease 2019, which was independent of preexisting conditions, severity and overall course of the acute illness, and the time from the original diagnosis.
Journal ArticleDOI

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Andrew J. Ullmann, +58 more
TL;DR: Treatment duration for aspergillosis is strongly recommended based on clinical improvement, degree of immunosuppression and response on imaging, and in refractory disease, where a personalized approach considering reversal of predisposing factors, switching drug class and surgical intervention is also strongly recommended.
Journal ArticleDOI

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Oliver A. Cornely, +79 more
TL;DR: Management of mucormycosis depends on recognising disease patterns and on early diagnosis, and limited availability of contemporary treatments burdens patients in low and middle income settings.
Journal ArticleDOI

Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

TL;DR: Isavuconazole showed activity against mucormycosis with efficacy similar to amphotericin B, and can be used for treatment of mucormYcosis and is well tolerated.